In a study from Koc University, scientists found metabolically healthy overweight and obese individuals may have an increased risk for chronic kidney disease (CKD).
CKD is a longstanding disease of the kidneys leading to renal failure.
The kidneys filter waste and excess fluid from the blood. As kidneys fail, waste builds up.
Symptoms develop slowly and aren’t specific to the disease. Some people have no symptoms at all and are diagnosed by a lab test.
There’s no cure for chronic kidney disease (CKD), but treatment can help relieve the symptoms and stop them from getting worse.
Your treatment will depend on the stage of your CKD. The main treatments are lifestyle changes – to help you stay as healthy as possible.
Medication helps manage symptoms. In later stages, filtering the blood with a machine (dialysis) or a transplant may be required.
The researchers conducted a systematic review and meta-analysis to examine the associations between obesity and CKD independent of metabolic syndrome by focusing on metabolically healthy obese people.
The team used data from 16 studies, with almost 5 million participants.
The researchers found that the risk for CKD was higher in overweight and obese patients compared with healthy normal-weight participants.
They say that the prevalence of metabolically healthy obesity is about 35 percent in obese people. Intervening for this condition could have important public health implications.
Clinical studies assessing whether lifestyle and pharmacologic treatment may prevent CKD and cardiovascular disease are needed in the metabolically healthy overweight and obese population.
If you care about kidney health, please read studies about how to protect your kidneys from diabetes, and sunlight could increase your risk of kidney damage.
For more information about kidney diseases, please see recent studies about the best protein source for your kidney health, and results showing how to improve outcomes of chronic kidney disease.
The study was conducted by Mehmet Kanbay et al and published in the European Journal of Clinical Investigation.
Copyright © 2022 Knowridge Science Report. All rights reserved.
